Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus

[1] Brinkmann V(1995)Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO− and CD45RO+subsets J. Immunol. 155 3322-3328

[2] Kristofic C(1996)Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients Am. J. Clin. Nutr. 63 373-376

[3] Bunout D(1993) secretion of interleukin-1β and interferon-γ by peripheral blood lymphomononuclear cells in diabetic patients Diabetes Res. Clin. Pract. 21 87-93

[4] Munoz C(1999)Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy Cardiovasc. Pathol. 8 145-151

[5] Lopez M(1996)Serum immunoreactive-leptin concentrations in normal-weight and obese humans New Engl. J. Med. 334 292-295

[6] de laMazaMP(2000)Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation Circulation 102 191-196

[7] Schlesinger L(1984)Interleukin-1 and the pathogenesis of the acte-phase response New Engl. J. Med. 311 1413-1418

[8] Hirsch S(1987)Lymphokines New Engl. J. Med. 317 940-945

[9] Pettermann M(1995)Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 28 137-146

[10] Ciampolillo A(1995)Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action Nature Med. 1 1311-1314

[1] Brinkmann V(1995)Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO− and CD45RO+subsets J. Immunol. 155 3322-3328

[2] Kristofic C(1996)Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients Am. J. Clin. Nutr. 63 373-376

[3] Bunout D(1993) secretion of interleukin-1β and interferon-γ by peripheral blood lymphomononuclear cells in diabetic patients Diabetes Res. Clin. Pract. 21 87-93

[4] Munoz C(1999)Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy Cardiovasc. Pathol. 8 145-151

[5] Lopez M(1996)Serum immunoreactive-leptin concentrations in normal-weight and obese humans New Engl. J. Med. 334 292-295

[6] de laMazaMP(2000)Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation Circulation 102 191-196

[7] Schlesinger L(1984)Interleukin-1 and the pathogenesis of the acte-phase response New Engl. J. Med. 311 1413-1418

[8] Hirsch S(1987)Lymphokines New Engl. J. Med. 317 940-945

[9] Pettermann M(1995)Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 28 137-146

[10] Ciampolillo A(1995)Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action Nature Med. 1 1311-1314